The diseases which were once thought to be incurable do find treatments or cure in due course of time with the progress of human research expertise. With the progress of science and technology new and improved drugs are found thus change in nature as well as human development appears as the course of life. In keeping with this, the Hathi Committee has held that a fixed or any constant number of inventions or research formulations are not sufficient to meet all the needs of time and nature.
Drawing back to the earlier case, Municipal Councli Ratlam vs Vardichand
The court observed that the conclusion/ findings of the Hathi Committee were not adequate as it does not reflect the current state of affairs. The World Health Organization in its report said that certain human ailments can be treated effectively with certain generic drugs.
It is accepted that the recommendation available to the World Health Organization was more accurate than that of the Hathi Committee for better resources. While the Court acknowledged that this is a grave health concern issue which may be transitory as situations do not remain the same.
The Central Government may formulate a national policy based on the expert advice which may prescribe a set number of formulations to meet the medical needs of people. The government ought to eliminate pernicious drugs form market from human consumption at the same time certain drugs needs to be manufactured distributed in greater quantity to meet the
1. The Joint Commission and the Agency for Healthcare Research and Quality developed standards and recommendations for healthcare organizations to employ in an effort to reduce the number of errors. In a few sentences, please discuss one recommendation.
The Medicines Act 1968:- The Medicines Act controls the manufacture and supply of medicines for human and veterinary use. The act defines three categories of the supply of drugs; Prescription only medicines, Pharmacy Medicine, and General sales list medicines the act controls
[of] a decision, policy or practice" that Khajavi reasonably believed, consistent with the standards of his profession, impaired his ability to provide medically appropriate health care to a patient within the meaning of section 2056. Indeed, the trial court had considered the evidence sufficient to go to the jury on this claim before it erroneously narrowed its interpretation of section 2056.
[of] a decision, policy or practice" that Khajavi reasonably believed, consistent with the standards of his profession, impaired his ability to provide medically appropriate health care to a patient within the meaning of section 2056. Indeed, the trial court had considered the evidence sufficient to go to the jury on this claim before it erroneously narrowed its interpretation of section 2056.
Romanow’s vision of a national formulary is intertwined with his larger recommendation of a national drug agency which would oversee the drug approval process, drug research and price-setting for the entire nation instead of each province and territory performing their own approvals (Romanow, 2002, p. 199). The national formulary would be based on a transparent evaluation process conducted by the agency and would erase the
The opinions of the physicians, staff and management present at today’s meeting exist as uncontrollable patient factors and controllable environmental factors.
In the United States of America, there is prescription drug abuse epidemic that continues to be a growing concern. Prescription drugs cause a large amount of overdoses and result in an abundant amount of deaths each year. A government study conducted shows this epidemic is scarily on the rise, “A recent government study found a 400% increase in prescription drug abuse between 1998 and 2008” (Schreiner 531). The excessive use of prescription drug abuse is leading to nonmedical use of the drugs, and creating addiction. Furthermore society is paying an extreme amount of money in this battle. With this drug abuse on the rise, legislators must create a law preventing doctors and pharmacists from over prescribing prescription medications as well a law to require they both participate in drug monitoring programs to prevent drug abuse. Now is the time that doctors and the pharmaceutical industry must be held accountable for their role in causing one of America’s worst addictions. The over medication of prescription drugs in the United States must be brought to an end by legislators creating laws to stop
Two completely different viewpoints of randomized clinical trials are given, article one is against the idea and article two is for it. Article one argues that when a patient sees a physician; the physician has the duty to provide the best treatment for that
we have to face the harsh reality of people misusing and abusing the use of painkillers, the question still remains, how are states acting upon implementing an action that will be specified to regulate the amount painkillers distributed by doctors to patients. If this new policy begins we will be able to analyze the changes that will affect the world be identifying this new policy we will be able to explain the macroeconomic consequence that will follow.
The improvement of medicine over the course of the human successes gave great convenience to the people of today. Science has cured and prevented many illnesses from occurring and is on its way to cure some of the most dreadful and harmful illnesses. As the world modernizes due to the industrialization, so does the ways of medicine. Some cures are approached by chance, some, through intense, scientific measures.
The Court’s conclusion and interpretation was correct in regards to this case. This was due to Morris J’s thorough research into the legislative history and legislative intentions of the Medical Treatment Act 1988 (Vic).
• Ensure the human rights of the participants in emerging countries associated with the predictable risks
Development of drugs with high potency and inhibitory activity against specific activating mutation, while showing significantly less activity against wild type mutations, made testing specific sensitizing mutation necessary. (1) (EGFR) T790M mutation a successful example of a biomarker for non-small cell lung cancer (NSCLC) treatment with Osimertinib that gained a wide acceptance in clinical practice in Europe and US (), One question that needs to be asked, however, is whether testing for similar mutations in different cancer will be of clinical value. an unknown subpopulation of patients with CRC will have an activating EGFR mutation, such as L858R, which is thought to activate the receptor constitutively, regardless of ligand status promoting cellular proliferation and growth. in patients with colorectal cancer, Targeting activated EGFR, hypothetically, will lead to growth inhibition of cancer cell dependent on the oncogenic drive of sensitising EGFR mutation.
Pharmaceutical Sciences is a topic that has interested me for a while now. What I can say about this topic is that it will help humanity grow as a whole and keep everyone moving forward. This is a topic where people really need to think about what goes behind the scenes of your average pharmacies. Once people start to think about it, they would start to realize that the science that happens is extremely crucial to mankind as we know it. Without this kind of science, where would humans be today? Would we have the ability to evolve the way we have? How far would humans make it to creating today’s future as we know it? The simple answer to all these questions is
Drug research is connected to a range of academic studies such as biology, pharmacology, medicinal chemistry and toxicology. Pharmaceutical researchers can design novel therapeutic drugs based on these studies above. The invention of new drug can be divided by function into two stages: drug discovery and drug development. Drug discovery is the process by which a new drug candidate is found and identified. Distinctively, bringing a new drug candidate to the market through clinical trials is called drug development. The first part of this essay provides an overview of drug discovery and pre-clinical research and development